Nitta Gelatin India Targets Wellness Boom with New ₹200-Cr Plant

Marking its 50th year of operations, Nitta Gelatin India Ltd (NGIL)—a joint venture between Nitta Gelatin, Japan, and the Kerala State Industrial Development Corporation—has announced a ₹200-crore expansion strategy to strengthen its position in the health-focused bio-products sector.

The investment includes the establishment of a new collagen peptide manufacturing plant, a modern gelatin production unit, and a corporate headquarters at Kakkanad, Kerala. The expansion aims to capitalize on the rapidly growing demand for collagen peptides, which are widely used in wellness, joint health, and metabolic care.

“Our upgraded facility will allow us to respond to this demand with scale and speed,” said Praveen Venkataramanan, Managing Director, NGIL. Having evolved over five decades from ossein production to high-grade pharmaceutical gelatin, NGIL now aspires to lead in clean-label and functional ingredient innovation.

Currently generating ₹500 crore in revenue, the company expects to reach ₹750–800 crore within two years following the expansion. As part of its golden jubilee celebrations on August 2, NGIL will also lay the foundation stone for its new facilities, underscoring its long-term commitment to India’s biotechnology and wellness industries.

News by Rahul Yelligetti.